Exim SEO Articles

How to Sell and Export Pharma Products from India: Complete Guide for Startup Merchant Exporters

Are you planning to start a pharmaceutical export business from India but worried about competition, finding buyers and convincing them to purchase from your company?

Many new entrepreneurs believe that success in pharmaceutical exports depends on having a famous brand, a large manufacturing factory or many years of experience.

However, pharmaceutical and surgical product businesses work differently from many ordinary trading businesses.

International healthcare buyers are not interested only in your company profile, product catalogue or manufacturing capacity.

They also want to know whether your product solves a genuine problem, whether its quality and performance can be verified, and whether your company can supply it reliably.

This creates an interesting opportunity for startup merchant exporters.

Even if you do not own a manufacturing factory, you can develop a business by understanding buyer problems, identifying suitable healthcare products, selecting qualified manufacturers and building a strong evidence-based sales approach.

But there is one important condition.

Pharmaceutical products affect human health. Therefore, every business strategy must be supported by product knowledge, appropriate scientific evidence and regulatory compliance.

Let us understand how Indian startup merchant exporters can approach pharmaceutical and surgical product sales through practical market research, product differentiation, buyer psychology and professional communication.

Why New Pharma Exporters Should Not Depend Only on Branding

Imagine that you have recently established a pharmaceutical export company.

You have designed an attractive company logo, developed a professional website and prepared a beautiful product catalogue.

Now you send an introductory email to an international pharmaceutical distributor.

Your email says:

"We are one of India's leading pharmaceutical exporters with excellent quality products and world-class services."

But your company has only recently started operating.

An experienced international buyer may investigate your business background, manufacturing relationships and regulatory documentation.

If your claims cannot be verified, the buyer may lose confidence.

This is a common mistake among new exporters.

Branding is important because it helps establish a professional identity.

However, a new company's branding cannot replace its actual business capabilities.

Instead of presenting yourself as an established multinational company, focus on explaining what practical value you can provide.

For example, a startup merchant exporter may work with licensed manufacturers, coordinate product verification, assist with regulatory documentation and arrange appropriate packaging and international shipments.

These capabilities can be more meaningful to buyers than unsupported claims about company size or experience.

Remember one important principle:

A new exporter does not need to pretend to be an old company. The exporter needs to demonstrate professional knowledge, reliable sourcing and genuine service.

How Established Pharmaceutical Companies Understand the Market: RCPA

One important market research method discussed in pharmaceutical sales is RCPA.

RCPA stands for Retail Chemist Prescription Audit.

It is a market research activity involving information collected from retail pharmacies and chemists to understand prescription and product movement patterns.

In suitable circumstances, RCPA may help companies understand which medicines are commonly dispensed within a particular market.

It can also provide information about competing brands, product demand and changes in purchasing patterns.

For example, imagine three pharmaceutical brands selling products in the same therapeutic category.

A company may study aggregated pharmacy sales or prescription-related trends to understand which products are frequently purchased and how demand differs between brands.

This information may help the business evaluate its commercial position.

However, RCPA data has important limitations.

Retail sales or prescription frequency does not automatically prove that a medicine is clinically superior.

The information may also be incomplete or affected by factors such as pricing, availability and distribution.

Companies must also respect patient confidentiality and applicable privacy requirements. Identifiable prescriptions or patient information should not be collected or shared without an appropriate lawful basis.

For large pharmaceutical companies, established market research may be one part of their commercial decision-making.

But what should a startup do when it has no sales history?

This is where a different approach becomes important.

Why Startups Should Focus on Customer Problems Before Product Sales

A new pharmaceutical exporter usually cannot compete with established companies using historical sales volumes.

An established company may already have thousands of customers and a recognized product portfolio.

A startup may have none of these advantages.

However, a startup can still investigate problems that buyers are experiencing.

For example, an international distributor may face difficulties such as inconsistent product availability, high procurement costs, unreliable delivery schedules, limited pack-size options or insufficient technical documentation.

A startup merchant exporter can study these problems and determine whether qualified Indian manufacturers can offer suitable solutions.

This changes the business discussion.

Instead of asking:

"Would you like to purchase our pharmaceutical products?"

The exporter can ask:

"Are you currently facing any challenges with product availability, technical documentation, packaging or consistent supply?"

This question encourages the buyer to discuss actual business requirements.

The exporter can then determine whether their company is capable of meeting those requirements.

This is called a problem-first approach.

The purpose is not to manufacture fear or persuade someone that they have a problem.

The purpose is to identify genuine requirements and provide suitable products or services.

Understanding Disease Potential and Future Healthcare Needs

Another important area of pharmaceutical market research is understanding how healthcare needs may change over time.

Different diseases create different requirements for medicines, diagnostics, surgical products and medical equipment.

For example, increasing demand for diabetes management may create opportunities for suitable diagnostic equipment and healthcare supplies.

Similarly, an ageing population may influence demand for certain orthopedic products and healthcare services.

However, disease prevalence should not be confused with product demand.

A country may have a large population affected by a particular condition but still have limited purchasing capacity, strict import regulations or established competing suppliers.

Therefore, startups should study both healthcare needs and the actual commercial market.

The COVID-19 Example: What Entrepreneurs Can Learn

During the COVID-19 pandemic, demand patterns changed significantly across several healthcare product categories.

Some products experienced temporary increases in consumer interest and sales.

This shows why businesses monitor healthcare developments and changing customer requirements.

However, there is an important distinction between responding to healthcare demand and making unsupported medical claims.

For example, a company should never promote an ordinary immunity supplement as preventing or treating COVID-19 without appropriate scientific evidence and regulatory authorization.

The practical lesson is to study changing healthcare needs, but never exploit public fear or make unverified treatment promises.

A sustainable pharmaceutical business should be based on genuine clinical relevance and lawful product claims.

Four Important Questions Buyers May Ask About a New Healthcare Product

When launching a pharmaceutical or surgical product, startups should understand how buyers evaluate unfamiliar products.

One useful way to organize this evaluation is through four questions.

These are not rigid scientific categories of buyers. They are practical questions that can help an exporter prepare a stronger presentation.

1. Emotional Confidence: Has the Product Been Tried and Tested?

A buyer may first want reassurance that the product has been used or evaluated before.

For example, a hospital procurement manager may ask whether the product is already being supplied to other healthcare institutions.

A new exporter can respond by providing genuine product samples, available evaluation reports, appropriate manufacturer references or relevant product history.

However, never invent customers, testimonials or clinical experience.

Trust should come from verifiable information.

2. Thinker: What Is the Evidence?

Some buyers concentrate on scientific and technical information.

They may ask for performance testing, regulatory approvals, quality certificates or comparative data.

For these buyers, general marketing statements are not sufficient.

An exporter should be prepared with product specifications and appropriate supporting evidence.

3. Sensor: How Does the Product Perform in Practice?

Another buyer may focus on practical performance.

For example, a healthcare distributor may ask how quickly a diagnostic device produces results.

A hospital buyer may want to understand the absorption performance of a wound dressing.

A surgical instrument distributor may ask about corrosion resistance and durability.

The exporter should explain the relevant performance characteristics using validated specifications.

4. Intuitor: What Is New or Different?

Some buyers may be interested in innovation and future opportunities.

They may ask what makes a new formulation, device or product design different from existing alternatives.

The exporter should explain genuine improvements.

However, a product being new does not automatically mean that it is better.

The improvement must be relevant, tested and supported by appropriate evidence.

Together, these four questions provide a practical presentation framework:

Has it been evaluated? What evidence supports it? How does it perform? What makes it different?

Why Product Innovation Can Be Risky for Startups

Competition encourages businesses to introduce new products.

However, introducing something new does not guarantee customer acceptance.

Consider an example from the consumer goods industry.

A toothpaste company may introduce a new variant containing an additional ingredient such as salt.

Some customers may find the new formulation interesting.

Others may continue purchasing their existing toothpaste because they are satisfied with it.

The new ingredient does not automatically create a reason for every customer to change brands.

The same principle applies to pharmaceutical and healthcare products, with much greater safety and regulatory responsibility.

A new formulation or product feature must solve a genuine problem.

A company should not assume that adding one more ingredient will automatically produce better clinical results.

This is why startups should conduct product research before launching new products.

Why Pharmaceutical Product Innovation Requires Special Care

Pharmaceutical innovation differs from ordinary consumer-product innovation.

A minor-looking change in a medicine may affect product stability, efficacy, safety, interactions or manufacturing requirements.

For example, adding a herbal ingredient to an existing cough syrup may change the formulation and its regulatory status.

The addition should not be presented as a clinical improvement unless suitable evidence supports that claim.

Therefore, merchant exporters interested in private-label pharmaceutical products should work with appropriately licensed manufacturers and qualified formulation, quality and regulatory professionals.

Changes in formulation, dosage or claims may require additional regulatory assessment or approval.

The correct strategy is not simply to add something new.

It is to identify a meaningful unmet need and determine whether a safe, effective and compliant solution can be developed.

How Traders and Merchant Exporters Have Become Important in Pharmaceutical Business

Traditionally, pharmaceutical manufacturers have relied on medical representatives, distributors and healthcare professionals to communicate product information and support distribution.

Manufacturers often developed relationships with doctors, hospitals and pharmacy networks.

However, modern pharmaceutical supply chains now involve many business models.

These include manufacturer-owned brands, marketing companies, merchant exporters, contract manufacturers and independent distribution companies.

A company does not always need to manufacture every product sold under its own brand.

For example, a medicine package may contain two separate details:

Manufactured by: The company responsible for producing the product.

Marketed by: The company responsible for marketing or distributing the brand, as applicable.

This arrangement helps explain how pharmaceutical marketing companies can build product portfolios without owning all the manufacturing infrastructure.

However, the legal responsibilities of manufacturers and marketers must be understood and properly documented.

The presence of a "Marketed by" label does not eliminate licensing, product quality or regulatory responsibilities.

Why This Matters for New Merchant Exporters

Many new exporters believe that a foreign buyer will always prefer dealing directly with the manufacturer.

However, some buyers prefer sourcing through a company that can coordinate multiple products, manufacturers and services.

For example, an international distributor may require medicines, selected surgical consumables and healthcare accessories.

The products may be manufactured by different Indian companies.

A merchant exporter with suitable supplier agreements and regulatory knowledge may coordinate the procurement and international supply.

This can create value for the buyer.

However, the merchant exporter should never misrepresent itself as the manufacturer.

The business should clearly explain its sourcing role and actual responsibilities.

Understanding the Difference Between Manufacturer-Driven and Market-Driven Business

A manufacturer often focuses on production capability, product development and manufacturing efficiency.

A trader or marketing company may focus more heavily on market access, customer preferences and distribution.

These responsibilities are different but complementary.

A manufacturer may develop an excellent product but need suitable distributors to reach particular markets.

A merchant exporter may understand overseas buyer requirements but depend on qualified manufacturers for production.

This creates opportunities for cooperation.

However, traders should not attempt to create artificial medical demand or influence clinical prescribing through improper incentives.

Healthcare product selection must remain based on patient needs, appropriate evidence and professional judgment.

A Practical Pricing Example: What Startups Must Understand

Consider a hypothetical cough syrup manufactured at a commercial cost of ?80 per bottle, including the manufacturer's assumed margin.

The manufacturer may decide to offer it at a selling price of ?100.

Now imagine that a separate marketing company develops a new formulation through a contract manufacturing arrangement.

Because of additional ingredients or manufacturing requirements, its product cost becomes ?85.

The marketing company decides to position the new product at ?200.

At first glance, the difference between ?85 and ?200 may appear attractive.

But this difference is not the company's actual profit.

The final selling price may include distribution margins, marketing expenses, taxes, product registration, logistics, returns and other commercial costs.

More importantly, the higher price does not prove that the modified medicine provides better treatment.

The original case discussed in the video also illustrates offers of larger financial incentives to doctors to encourage prescriptions.

That is not an acceptable business strategy.

India's Uniform Code for Pharmaceutical Marketing Practices, 2024, restricts and prohibits improper gifts and monetary benefits to healthcare professionals, and the applicable ethical and legal rules must be respected.

Entrepreneurs should compete through verified quality, genuine clinical relevance, appropriate product availability and responsible pricing—not payments intended to influence prescribing decisions.

This is a critical distinction for anyone entering pharmaceutical sales.

The Licorice Example: Why a New Ingredient Is Not Enough

Suppose a manufacturer produces an existing cough syrup.

A marketing company proposes adding Yashtimadhu, commonly known as licorice.

The company believes that the modified formulation will be attractive to customers.

However, the presence of licorice does not automatically make the syrup more effective or safer.

The company must investigate the ingredient's suitability, evidence, possible interactions, applicable regulations and overall formulation quality.

The product also requires appropriate testing and documentation.

If the new product demonstrates a genuine, authorized benefit, that difference may become part of its commercial positioning.

But making unsupported medical claims can mislead healthcare professionals and patients.

For startup merchant exporters, this example teaches an important principle:

Product differentiation is valuable only when the difference is meaningful and can be demonstrated.

How to Identify Real Product Differentiation

A new product does not always need a completely new formula.

Sometimes buyers need improvements in existing products.

For example, a healthcare distributor may need a product with better protective packaging or a longer validated remaining shelf life at delivery.

Another buyer may require smaller pack sizes for a particular market.

A hospital supplier may need more reliable batch traceability or technical documentation.

A merchant exporter may create value by arranging these requirements through an appropriately qualified manufacturer.

Possible areas of differentiation include product specifications, packaging, documented performance, supply reliability, distribution support and commercially suitable order quantities.

However, every proposed improvement must be evaluated according to the product's regulatory requirements.

The best differentiation is something the customer actually needs and the exporter can consistently deliver.

Why Ordinary Commodity Trading Is Not Always Easier Than Pharma Trading

Many entrepreneurs believe that exporting onions, potatoes or other agricultural products is easier than exporting healthcare products.

At first glance, agricultural commodities may appear simpler because they do not involve the same medical-device or pharmaceutical regulatory systems.

However, commodity trading has its own challenges.

An experienced agricultural exporter may need to understand product varieties, harvesting cycles, seasonal prices, grading, sorting, storage, spoilage and international buyer preferences.

For example, successful potato exporters may understand the characteristics of different varieties and how storage conditions affect quality.

An inexperienced exporter may lose money if the product deteriorates during transportation or fails to meet the buyer's specifications.

Therefore, no export product should be considered easy simply because it is familiar.

Pharmaceutical products have different challenges.

These include licensing, quality assurance, product registration, stability, safety and technical documentation.

Neither sector is automatically easier.

The correct comparison depends on the entrepreneur's knowledge, resources, suppliers and target market.

Why Problem Knowledge Is Important in Healthcare Sales

A new healthcare exporter may not have the same technical knowledge as an experienced doctor or pharmacist.

However, the exporter can learn to identify practical problems faced by healthcare institutions and distributors.

For example, consider a hospital distributor that regularly supplies wound dressings.

Its concerns may include inconsistent availability, damaged packaging, short remaining shelf life or inadequate product documentation.

A merchant exporter who understands these issues can discuss suitable sourcing solutions.

This is different from attempting to teach a doctor how to treat a patient.

Clinical decisions belong to qualified healthcare professionals.

The exporter's role is to understand product requirements and provide accurate information about the products being offered.

The most productive business conversation often begins with a genuine problem rather than a sales claim.

How to Apply the Problem-First Approach

Suppose you are contacting an international buyer of surgical dressings.

Instead of writing:

"We supply high-quality surgical dressings from India at competitive prices."

You could begin by understanding whether the buyer experiences any procurement or supply challenges.

For example, the buyer may have difficulty obtaining small order quantities or maintaining consistent packaging specifications.

If your company can address these requirements, you have a meaningful reason to continue the discussion.

A practical problem-first approach involves five activities.

First, identify the buyer's product category and business model.

Second, research possible operational or procurement challenges.

Third, ask suitable questions instead of assuming that every buyer has the same problem.

Fourth, explain how your sourcing arrangements may address the identified requirements.

Fifth, provide verifiable information and agree on the next evaluation step.

The objective is to build a professional relationship based on understanding and service.

Understanding the Traditional AIDA Sales Funnel

Many businesses use the AIDA marketing model.

AIDA stands for Attention, Interest, Desire and Action.

The basic idea is that a potential customer first notices a product, develops interest, considers its value and then makes a purchasing decision.

For example, an international buyer may notice a new product in an email or trade exhibition.

The buyer may then request technical information.

If the product appears suitable, the buyer may consider obtaining samples or a quotation.

Finally, the buyer may place an order.

However, pharmaceutical and medical-device purchasing frequently involves additional evaluation.

A buyer may need to understand technical risks, regulatory obligations, clinical evidence and supply reliability before proceeding.

This introduces another useful concept: Concern.

The AIDCA Approach for Pharmaceutical Sales

A practical framework discussed in the video is AIDCA.

It stands for Attention, Interest, Desire, Concern and Action.

This is a useful adaptation of the traditional AIDA framework for organizing healthcare sales conversations.

It should be treated as a practical communication model rather than a scientifically proven universal sequence.

Let us understand each stage.

Attention

At this stage, the exporter introduces a relevant product or a genuine customer problem.

For example, the exporter may explain that the company specializes in supplying selected medical products with documented quality specifications.

Interest

The buyer becomes interested when the product matches an actual requirement.

For example, the buyer may need a particular packaging format or approved product specification.

Desire

The buyer begins considering the practical value of the proposed supply arrangement.

This may involve suitable pricing, reliable availability, quality documentation or delivery support.

Concern

The buyer evaluates possible problems and risks.

For example:

Is the manufacturer qualified?

Does the product comply with local regulations?

Are the test reports valid?

What happens if the shipment is delayed?

Who will handle quality complaints?

Does the product have sufficient shelf life?

These are important concerns in healthcare procurement.

Action

The buyer proceeds when the necessary questions have been answered and the commercial conditions are acceptable.

The next step may be a technical evaluation, sample approval, supplier registration or purchase order.

For startup merchant exporters, the Concern stage deserves particular attention.

A buyer may be interested in your product but still refuse to place an order because the documentation or supply process is unclear.

Therefore, successful sales communication requires more than creating interest.

It requires reducing uncertainty through reliable information.

How Can Startups Understand Buyer Concerns Without a Pharma Background?

Many entrepreneurs want to enter healthcare exports but have limited pharmaceutical knowledge.

This does not mean they must abandon the business.

However, they must develop the knowledge needed to make responsible commercial decisions.

Fortunately, several educational and industry resources are available.

One important area is Continuing Medical Education.

What Is CME?

CME stands for Continuing Medical Education.

It refers to educational activities that help medical professionals maintain and improve their knowledge.

The broader term Continuing Professional Development, or CPD, is also used in healthcare education.

Medical knowledge changes as new research, technologies and clinical guidelines become available.

Therefore, healthcare professionals need opportunities to update their understanding.

CME and CPD activities may cover developments in diagnosis, treatment, medical technologies and professional practice.

However, these programmes are primarily designed for healthcare professionals.

A merchant exporter may not automatically qualify for every medical education programme or professional credit.

Nevertheless, publicly available educational materials, suitable industry conferences and regulatory workshops can help businesspeople understand the sector.

Where Can Indian Pharma Exporters Learn?

1. National Medical Commission

The National Medical Commission provides information related to medical education and professional regulation in India.

Its official website can help entrepreneurs identify relevant professional education frameworks.

Website: https://www.nmc.org.in/

2. Pharmexcil

The Pharmaceuticals Export Promotion Council of India, commonly known as Pharmexcil, is an important organization for the Indian pharmaceutical export industry.

It publishes trade-related information, circulars and announcements concerning international market access.

For example, Pharmexcil has organized or circulated information about export compliance workshops, overseas market opportunities and regulatory matters.

Startup exporters can study these resources and participate in appropriate programmes where eligible.

Website: https://pharmexcil.com/

3. Export Promotion Council for Medical Devices

The Export Promotion Council for Medical Devices, or EPCMD, supports the promotion of Indian medical-device exports.

Its role includes activities related to international trade promotion, exporter awareness and industry development.

This can be relevant to entrepreneurs working with surgical products, diagnostic devices and other medical equipment.

4. CDSCO

The Central Drugs Standard Control Organisation is a key source of information about pharmaceutical and medical-device regulation in India.

Its website provides regulatory notices, guidance documents and other important information.

Website: https://www.cdsco.gov.in/

5. Scientific Publications and Professional Education

Exporters may also study peer-reviewed research, recognized medical journals and educational resources from relevant professional organizations.

However, research should be interpreted carefully.

A published article does not automatically establish that a particular commercial product is safe, effective or approved in a specific country.

The objective of learning is to improve the exporter's understanding—not to replace clinical or regulatory expertise.

How Product Education Improves Buyer Presentations

Suppose you want to export a diagnostic device.

Without sufficient knowledge, your sales presentation may include only the device name, photograph and quotation.

But after studying the product, you may understand its intended use, testing method, accuracy requirements, consumables, maintenance and regulatory documentation.

Your presentation can then answer more meaningful buyer questions.

Similarly, when selling surgical dressings, you may learn about material specifications, absorption performance, sterility and packaging.

This knowledge improves your ability to evaluate suppliers and communicate with buyers.

A professional exporter should understand not only what the product is, but also why the buyer needs it, what limitations it has and what evidence supports its performance.

How to Approach International Pharmaceutical Buyers Through Email

One common question among startup merchant exporters is how to write the first email to an overseas pharmaceutical buyer.

Many entrepreneurs send a general company introduction followed by a long list of products.

However, experienced healthcare buyers receive many similar messages.

A more useful email should be short, relevant and supported by genuine product information.

The goal should be to begin a professional discussion rather than immediately pressure the buyer to purchase.

What Should the Email Subject Line Include?

A suitable subject line should communicate the product category or business requirement clearly.

For example:

Indian Pharmaceutical Sourcing – Product Documentation and Supply Discussion

Or:

Surgical Dressing Supply from India – Technical Specifications and Manufacturer Details

Or:

Pharmaceutical Portfolio Sourcing – Availability and Regulatory Documentation

These subject lines are more informative than generic messages such as "Best Price Offer" or "Top Pharmaceutical Exporter."

They also avoid unsupported claims about clinical results.

What Information Should Be Included in the Email?

A professional introduction should contain the following elements.

First, briefly introduce your company and its actual role.

Second, mention the relevant product category.

Third, explain why you are contacting that particular buyer.

Fourth, describe the available technical or regulatory documentation.

Fifth, mention any genuine sourcing advantage.

Sixth, invite the buyer to share appropriate procurement or technical requirements.

The email should demonstrate that you understand the buyer's business.

A Practical Introductory Email for a Startup Merchant Exporter

Subject: Pharmaceutical Product Sourcing from India – Technical and Supply Discussion

Dear Sir/Madam,

Greetings from Barai Overseas, India.

We work in international business development and sourcing support for selected pharmaceutical, surgical and healthcare product categories.

We understand that healthcare distributors need reliable product availability, appropriate documentation and consistent manufacturing quality.

We would like to explore whether our Indian sourcing network can support any of your current procurement requirements.

Based on the selected product and qualified manufacturing partner, we can coordinate available technical specifications, manufacturer documentation, product samples and commercial supply information for your evaluation.

We would be interested in understanding your present product requirements, preferred specifications and any challenges you may face with availability, packaging or supply coordination.

This will help us determine whether we can offer a suitable sourcing solution.

We look forward to the possibility of a professional discussion.

Best regards,

Barai Overseas

https://www.exportimport.guru/

This is a general business-to-business sourcing email.

For prescription medicines and regulated medical devices, product promotion and communication must follow the relevant laws of the destination country.

Product-specific claims should be added only after verifying their accuracy and regulatory suitability.

Why Scientific Communication Can Be More Effective Than Aggressive Selling

International pharmaceutical buyers often need technical evidence before approving a new product or supplier.

For example, a procurement manager may request product specifications and manufacturing documents.

A hospital technical committee may require evidence relevant to a medical device.

A pharmaceutical importer may need registration documents and information about the manufacturer's quality systems.

An email that provides clear and verifiable information can therefore be more useful than one focused only on discounts and promotional language.

This leads to an important professional concept: the Medical Science Liaison approach.

What Is a Medical Science Liaison?

A Medical Science Liaison, commonly called MSL, is generally a scientifically trained professional working in medical affairs.

The role often involves scientific exchange with healthcare professionals and other relevant experts.

MSLs are different from traditional promotional sales representatives because their scientific responsibilities and non-promotional obligations are distinct.

Startup exporters can learn an important communication principle from this approach.

Provide accurate information.

Understand the questions being asked.

Discuss available evidence.

Recognize the limitations of the product.

Do not exaggerate benefits.

However, a merchant exporter should not claim to be an MSL or present ordinary promotional sales activity as independent medical scientific communication.

The correct approach is to adopt evidence-based and professional communication while remaining transparent about the company's commercial purpose.

How to Make a Pharmaceutical Buyer Email More Relevant

A good introductory email should not simply say that the company offers an extensive pharmaceutical portfolio.

It should explain why the proposed products may be relevant to the buyer.

For example, a distributor may be interested in expanding into a related product category.

Another distributor may need additional qualified suppliers to improve supply-chain resilience.

A third company may be searching for different pack sizes or suitable documentation for a particular market.

A startup exporter should research the buyer's existing portfolio and determine whether the proposed products are genuinely relevant.

The discussion may include clinical relevance, product utility, regulatory status, portfolio compatibility, market sustainability and supply advantages.

If a product has a relevant patent, licensing arrangement or other intellectual property considerations, these should also be verified.

However, patent status should not be presented as proof of clinical effectiveness.

The objective is to help the buyer determine whether the product fits their business.

How to Discuss Unmet Healthcare Needs Responsibly

An important point discussed in the video is that pharmaceutical businesses must continue responding to changing healthcare requirements.

Some medical conditions remain difficult to treat.

Other conditions may have available treatments but limited access, high costs or inadequate distribution in particular markets.

These situations can create genuine healthcare needs.

However, exporters should avoid presenting a condition as incurable without reliable clinical evidence.

They should also avoid suggesting that a new product can solve a problem when its effectiveness has not been established.

A more responsible business discussion may focus on treatment access, product availability, affordability or documented improvements in quality and performance.

For example, a distributor may be facing recurring shortages of an approved medicine.

An exporter working with a qualified manufacturer may explore whether reliable supply can be arranged.

This is a genuine procurement problem.

It does not require exaggerated disease claims or artificial urgency.

Why Product Portfolio Planning Matters

Pharmaceutical and healthcare distributors may deal in multiple product categories.

A merchant exporter who understands related product requirements may be able to develop a more useful sourcing portfolio.

For example, a healthcare distributor purchasing selected surgical consumables may also require related wound-care products.

Similarly, a dental distributor may source several compatible dental product categories.

However, adding products without a clear business strategy can create unnecessary complexity.

Each new product may involve separate regulatory requirements, technical documentation, supplier verification and commercial costs.

Therefore, a startup should begin with a focused portfolio.

Once the company develops reliable sourcing and buyer relationships, it can consider expanding into related categories.

The objective should be to increase customer value rather than simply create the longest possible catalogue.

How to Build a Practical Product Research Report

Before approaching international buyers, startups should prepare a structured product research report.

This report can become the foundation for supplier discussions, costing and buyer presentations.

A useful report should cover the following areas.

1. Product Identification

Include the product name, description, intended use and relevant category.

2. Clinical or Practical Application

Explain the purpose of the product and the type of customer who may require it.

3. Existing Alternatives

Identify competing products and relevant differences.

4. Customer Problems

Study whether buyers face problems related to performance, pricing, availability, documentation or other relevant factors.

5. Technical Specifications

Include the important specifications that can be verified.

6. Manufacturer Qualifications

Record manufacturing licences, available certifications and relevant quality information.

7. Product Safety and Performance

Identify the evidence supporting permitted product claims.

8. Target Market Requirements

Document applicable import, registration and labelling obligations.

9. Pricing and Commercial Costs

Estimate procurement, logistics and other relevant expenses.

10. Buyer Categories

Identify the importers, distributors or healthcare businesses that may purchase the product.

11. Sourcing Advantages

Explain what practical value the merchant exporter can provide.

12. Risks and Limitations

Include regulatory uncertainty, supplier dependency, commercial competition and other important risks.

This report helps the exporter move beyond simple catalogue-based selling.

How to Convert a Buyer Concern into a Business Opportunity

Consider an international distributor who is interested in importing selected pharmaceutical products from India.

The buyer may already have suppliers.

Therefore, the exporter must identify a genuine reason for the buyer to consider another company.

Suppose the buyer is concerned about delayed shipments.

The exporter can investigate whether a qualified manufacturer can provide a more dependable supply schedule.

Next, the exporter can discuss realistic lead times, available stock, production planning and shipment arrangements.

If the proposed arrangement is feasible, the buyer may agree to evaluate it.

Now suppose the buyer is concerned about documentation.

The exporter can request the relevant manufacturer records and explain what documents can be provided.

Again, the goal is to address a real concern.

Not every buyer concern can be solved.

Sometimes the exporter must admit that the company does not currently have the required capability.

This is better than making promises that cannot be fulfilled.

How to Present Your Business as a Merchant Exporter

When an overseas buyer asks whether you are a manufacturer or merchant exporter, answer truthfully.

For example:

"We are an Indian merchant-export and sourcing company. We work with selected manufacturers and coordinate product sourcing, technical documentation and export requirements according to the buyer's needs."

This explanation is more useful than simply saying:

"We are traders."

However, do not claim to conduct laboratory testing, factory audits or quality certification unless you actually perform or properly arrange those services.

The strongest positioning comes from genuine capability.

A merchant exporter may not control manufacturing directly, but can coordinate and verify agreed sourcing processes through suitable contracts and qualified partners.

This can be valuable to buyers who need support managing multiple suppliers.

Why Quality Documentation Can Help Win Export Orders

Healthcare products often require more detailed documentation than ordinary merchandise.

Depending on the product and destination market, buyers may ask for manufacturing licences, GMP-related documentation, Certificates of Analysis, stability information, technical specifications or product registration records.

Medical-device buyers may require applicable ISO 13485 information, device registration or conformity documentation.

The correct documents depend on the product.

A merchant exporter should not assume that every pharmaceutical or medical product requires the same certificates.

For example, requirements for an approved tablet formulation may differ considerably from those for a sterile medical dressing or diagnostic analyser.

Before offering a product, confirm what the destination country requires and whether the selected manufacturer can supply the necessary documentation.

This avoids situations where the exporter receives a purchase order but cannot legally complete the transaction.

What Legal Requirements Should Indian Merchant Exporters Consider?

Pharmaceutical and medical-device exporting is a regulated business.

The exact requirements depend on the product, business role and destination market.

In India, exporters generally need an Importer Exporter Code unless a specific exemption applies.

Relevant business, tax, customs and banking requirements must also be addressed.

Pharmaceutical products may involve drug licensing, manufacturer authorization and specific export documentation.

Certain new, unapproved or otherwise restricted drug products intended solely for export require particular CDSCO procedures.

Medical devices follow the applicable medical-device regulatory framework.

Exporters must also confirm the importing country's registration and market-access requirements.

An Indian product licence does not automatically authorize sales in another country.

Merchant exporters should coordinate with the manufacturer, qualified regulatory professionals and the overseas importer before accepting an order.

Responsible Marketing: A Critical Requirement for Pharma Startups

Pharmaceutical marketing is not the same as ordinary consumer-product advertising.

A promotional statement about a healthcare product can influence treatment decisions.

Therefore, accuracy and professional ethics are essential.

India has established the Uniform Code for Pharmaceutical Marketing Practices, 2024.

A separate Uniform Code for Marketing Practices in Medical Devices, 2024, also applies to relevant medical-device marketing activities, with subsequent amendments.

These frameworks address ethical promotion and interactions with healthcare professionals.

The World Health Organization's ethical criteria for medicinal drug promotion also emphasize truthful, balanced and substantiated claims.

For a startup, the practical lesson is clear.

Do not offer improper financial benefits to influence medical prescribing.

Do not exaggerate safety or efficacy.

Do not misrepresent clinical research.

Do not promote an unapproved indication.

Do not conceal important product limitations.

Do not present commercial advertising as independent scientific advice.

A business that follows these principles is better positioned to develop trustworthy long-term relationships.

How to Negotiate with International Pharmaceutical Buyers

A buyer may be interested in your product but still have concerns about price, payment terms, minimum order quantities or delivery.

A merchant exporter should understand these matters before negotiating.

For example, if the buyer requests a small trial order, the exporter should check whether the manufacturer can supply the required quantity.

If the buyer requests private-label packaging, the exporter should determine whether the manufacturer can provide it under the applicable regulatory framework.

If the buyer requests credit terms, the exporter should evaluate the financial risk.

Possible payment arrangements may include advance payment or suitable letters of credit, depending on the transaction.

The objective is not to accept every buyer demand.

It is to establish commercially viable terms that both parties can fulfil.

How to Calculate the Profitability of a Pharma Export Order

A pharmaceutical product may have a high selling price, but the exporter must calculate its actual costs.

The total export cost may include procurement, packaging, quality inspection, inland transportation, customs documentation, freight, insurance, banking charges and product-specific compliance expenses.

The exporter may also need to consider regulatory registration costs, shelf-life requirements, inventory holding and possible rejected shipments.

Therefore, comparing the Indian factory price with an overseas retail price is not sufficient.

A practical business model should calculate the complete cost under the agreed delivery terms.

It should also identify who is responsible for product registration, import clearance, local taxes and distribution.

Startups should avoid selecting products only because their advertised gross margins appear attractive.

The real opportunity is determined by the complete transaction economics.

A 30-Day Practical Learning and Business Preparation Plan

A new merchant exporter can use the following roadmap to organize the first stage of business development.

Days 1–5: Select and Understand the Product

Choose one pharmaceutical or healthcare product category.

Study its intended use, specifications, manufacturer requirements and basic regulatory classification.

Avoid beginning with too many unrelated products.

Days 6–10: Study the Market and Customer Problems

Identify potential destination countries and suitable buyer categories.

Research competing products, distribution arrangements, procurement requirements and possible customer concerns.

Days 11–15: Evaluate Manufacturers

Contact qualified Indian manufacturers.

Request product information, commercial quotations, available quality documentation and suitable samples.

Study the supplier's production and delivery capabilities.

Days 16–20: Prepare the Business Presentation

Develop a product-focused presentation.

Explain the product's relevant specifications, available evidence, sourcing arrangements and commercial advantages.

Also prepare a professional introductory email.

Days 21–25: Begin Buyer Research and Outreach

Identify relevant international importers, distributors and procurement companies.

Approach them with accurate and targeted communication.

Focus on understanding their requirements rather than immediately pushing for an order.

Days 26–30: Review Buyer Responses

Evaluate the questions received from buyers.

Identify common concerns relating to quality, documents, availability, pricing or regulatory requirements.

Use these findings to improve your sourcing strategy and presentations.

This is a business-preparation roadmap, not a guarantee that a pharmaceutical export order can be completed within 30 days.

Actual timelines depend on the product, supplier, regulatory approvals and buyer decisions.

Common Mistakes New Pharma Exporters Should Avoid

One common mistake is claiming to have extensive experience when the company is newly established.

Another is approaching buyers without understanding the product.

Some startups focus only on offering the lowest price.

Others introduce new product formulations without properly evaluating their scientific or regulatory requirements.

Another mistake is assuming that international healthcare buyers will purchase a product simply because it contains an additional ingredient or an attractive label.

Some exporters also promise certifications, product availability or delivery schedules before confirming the manufacturer's capabilities.

And perhaps the most serious mistake is attempting to influence healthcare product selection through unsupported medical claims or improper incentives.

All these practices can damage buyer confidence and create serious commercial or regulatory problems.

The better approach is to develop genuine expertise, communicate transparently and build repeatable sourcing systems.

The Biggest Lesson: Sell the Solution, Not Just the Product

The most important message from this entire discussion is that a pharmaceutical export startup should not depend only on branding, sales language or aggressive marketing.

Instead, the business should develop a clear understanding of customer problems.

A buyer may need a reliable supply of an existing medicine.

Another buyer may need better product documentation.

A hospital supplier may require a different packaging format.

A medical distributor may need a suitable product portfolio from qualified Indian manufacturers.

These are practical business requirements.

A merchant exporter who can identify such requirements and provide reliable solutions may create a meaningful position in the supply chain.

However, the solution must be genuine.

Product quality must be verified.

Medical claims must be supported.

Regulatory obligations must be satisfied.

Commercial promises must be realistic.

A new company may not have a large brand, but it can still earn confidence through knowledge, transparency and professional service.

Final Thoughts: How Indian Startup Merchant Exporters Can Build a Strong Pharma Business

India offers opportunities across pharmaceutical manufacturing, medical devices, surgical consumables and healthcare-related international trade.

However, entering these industries requires careful planning.

Startup merchant exporters should understand that success does not come simply from selecting a popular product or approaching hundreds of international buyers.

It comes from choosing a suitable product, understanding customer requirements and developing reliable supply capabilities.

Market research methods such as RCPA can help established businesses understand product movement, while startups can begin by studying market gaps and buyer concerns.

Product differentiation can create value, but only when improvements are meaningful and supported by evidence.

Practical buyer psychology can help organize sales communication, but it must never replace scientific accuracy.

The AIDCA framework reminds entrepreneurs to address buyer concerns before expecting a purchasing decision.

CME, professional education, Pharmexcil resources and other credible industry programmes can help exporters build knowledge, within their appropriate scope.

An MSL-inspired evidence-based communication style can improve the quality of technical discussions, provided the exporter remains honest about their commercial role.

And a problem-first introductory email can help begin a more meaningful relationship with international buyers.

Remember one important business principle:

Your buyer may forget your company introduction, but they are more likely to remember a supplier who understands their problem and provides a dependable solution.

For an Indian startup merchant exporter, this is an important foundation for long-term business development.

At Barai Overseas, we focus on helping entrepreneurs understand pharmaceutical and surgical product selection, international market research, practical buyer communication, manufacturer sourcing and export business development.

The objective is to help startups move beyond ordinary product trading and develop real expertise in international business.

Watch Our Complete Video Series

1. How to Sell Pharma Products as a New Startup

https://www.youtube.com/watch?v=6KoUD68laK4

2. The Secret Behind Traders' Success in Pharma – Part 1

https://www.youtube.com/watch?v=4PS970NUbY4

3. The Secret Behind Traders' Success in Pharma – Part 2

https://www.youtube.com/watch?v=qoftbG6P3dc

4. The Problem-First Approach: How Startups Win Pharma Deals

https://www.youtube.com/watch?v=ThAfx0uWXh8

5. Pharma Sales Funnel Mastery: Turning Concern into Conversion

https://www.youtube.com/watch?v=Skn9DoaXC0c

6. How Pharma Startups Can Approach Buyers – Intro Email Format

https://www.youtube.com/watch?v=CFsw-ip5C04

Useful Official Resources

1. Uniform Code for Pharmaceutical Marketing Practices, 2024

https://www.pharma-dept.gov.in/en/policy/uniform-code-pharmaceutical-marketing-practices-ucpmp-2024-reg

2. Uniform Code for Marketing Practices in Medical Devices, 2024

https://www.pharma-dept.gov.in/en/policy/uniform-code-marketing-practices-medical-devices-ucmpmd-2024

3. National Medical Commission

https://www.nmc.org.in/

4. Pharmaceuticals Export Promotion Council of India

https://pharmexcil.com/

5. Central Drugs Standard Control Organisation

https://www.cdsco.gov.in/

6. Directorate General of Foreign Trade

https://www.dgft.gov.in/

7. World Health Organization – Ethical Criteria for Medicinal Drug Promotion

https://iris.who.int/handle/10665/38125

For more export-import business knowledge, practical product research and international trade education, visit:

https://www.exportimport.guru/

Hare Krishna.

Barai Overseas | AI Export Import Guru

Tags: How to Sell and Export Pharma Products from India: Complete Guide for Startup Merchant Exporters